(19)
(11) EP 3 164 403 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.10.2018 Bulletin 2018/42

(45) Mention of the grant of the patent:
29.08.2018 Bulletin 2018/35

(21) Application number: 15733736.1

(22) Date of filing: 02.07.2015
(51) International Patent Classification (IPC): 
C07D 487/14(2006.01)
A61P 25/00(2006.01)
 A61K 31/4985(2006.01)
(86) International application number:
PCT/EP2015/065063
(87) International publication number:
WO 2016/001345 (07.01.2016 Gazette 2016/01)

(54)

TRICYCLIC TRIAZOLIC COMPOUNDS

TRICYCLISCHE TRIAZOLISCHE VERBINDUNGEN

COMPOSANTS TRIAZOLIQUES TRICYCLIQUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 02.07.2014 EP 14382254

(43) Date of publication of application:
10.05.2017 Bulletin 2017/19

(73) Proprietor: ESTEVE PHARMACEUTICALS, S.A.
08038 Barcelona (ES)

(72) Inventors:
  • CUEVAS-CORDOBÉS, Félix
    E-28340 Valdemoro (Madrid) (ES)
  • PERICÁS-BRONDO, Miguel, Angel
    E-08950 Espluges de Llobregat (Barcelona) (ES)

(74) Representative: Herrero & Asociados, S.L. 
Cedaceros, 1
28014 Madrid
28014 Madrid (ES)


(56) References cited: : 
WO-A1-2009/071657
   
  • SNYDER S H ET AL: "RECEPTOR MECHANISMS IN ANTIPSYCHOTIC DRUG ACTION: FOCUS ON SIGMA RECEPTORS", JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCE, AMERICAN PSYCHIATRIC PRESS, WASHINGTON, DC, US, vol. 1, no. 1, 21 December 1989 (1989-12-21), pages 7-15, XP001087814, ISSN: 0895-0172
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).